NCT07385963Not yet recruiting
Correlation Between EIT-based Pulse Wave Method for Pulmonary Perfusion Monitoring and Pulmonary Artery Catheter-based Stroke Volume Measurement
EIT-Based Pulmonary Perfusion Pulse Wave Versus Swan-Ganz Catheter in Stroke Volume Correlation
Source: ClinicalTrials.gov · Last updated 4 Feb 2026
Brief summary (registry, in English)
The goal of this clinical study is to learn if a new, non-invasive monitoring method called EIT Pulse Wave can accurately measure blood flow to the lungs (pulmonary perfusion) and predict heart stroke volume (SV) in critically ill patients. It will also learn about the safety of this monitoring approach. The main questions it aims to answer are: How well does the EIT Pulse Wave measurement of lung blood flow correlate with the SV measured by the standard method (Swan-Ganz catheter)? Can we build a reliable model to predict SV non-invasively using the EIT Pulse Wave signal? Researchers will compare the EIT Pulse Wave measurements directly with the Swan-Ganz catheter measurements to see if the new method is accurate. Participants will: Be critically ill adults in the ICU who are already receiving mechanical ventilation and have a Swan-Ganz catheter in place for medical reasons. Undergo simultaneous monitoring using both the EIT device and the Swan-Ganz catheter every 30 minutes for up to 48 hours. Have their ventilator settings adjusted to different levels as part of the study protocol while both measurements are recorded.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 19 (estimated)
- First submitted
- 11 Dec 2025
- Start date
- 2 Feb 2026
- Primary completion date
- 15 Feb 2027
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Diseases
- Stroke
- NCT number
- NCT07385963
What you commit to
- Study type: Observational
- Planned participants: 19
- From 2 Feb 2026 to the primary completion date, 15 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing ECMO therapy.
Other illness
- Arrhythmia.
- Failure to provide signed informed consent.
Age
- Age under 18 years or over 80 years.
Other
- Patients with severe obesity (BMI ≥ 35 kg/m²).
- Pregnant or lactating women.
- Pulmonary embolism.
- Contraindications to EIT monitoring.
- Contraindications to pulmonary artery catheter use.
Who the study is looking for
- Critically ill patients requiring mechanical ventilation support.
- Patients meeting the 2023 global ARDS definition and/or shock patients receiving vasoactive medication therapy.
- Patients who have already had a pulmonary artery catheter inserted due to clinical needs.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.